Lung CT Market 2026: Primary Research + Expert Analysis

Lung CT by Application (Hospital, Clinic, Other), by Types (2S Spiral Scan CT, 16S Spiral Scan CT, 64S Spiral Scan CT, 128S Spiral Scan CT, 256S Spiral Scan CT, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2780 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2780 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lung CT Market Overview

The Lung CT market—comprising low-dose CT (LDCT) scanners, AI image-analysis software, and associated services—refers to the global revenue pool generated by technologies used to detect, stage, and monitor pulmonary nodules and lung cancer. With lung cancer remaining the deadliest malignancy worldwide, the Lung CT market size is poised for decisive industry expansion as screening programmes move from pilot to reimbursed status across major economies.

Loading chart…

Valued at roughly USD 3.95 billion in 2025, the Lung CT market forecast points to a high-single-digit CAGR toward 2033, propelled by favourable reimbursement (CMS 2025 final rule), rising screening eligibility in high-risk cohorts, and continuous technology shifts toward photon-counting and ultra-low-dose protocols. Key forces reshaping competitive intensity include: (1) rapid FDA clearances for cloud-native AI that slashes radiologist read times; (2) updated USPSTF and EU Council guidelines widening the eligible population; and (3) supply-chain re-shoring of critical detector components. North America retains the largest revenue share thanks to mature LDCT infrastructure, while APAC—led by China and Japan—will be the fastest-growing region on the back of national screening mandates and accelerated hospital digitisation.

Report Overview

Report Attribute	Details
Market size value in 2025	2.78 billion
Revenue forecast in 2033	4.57 billion
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens; Philips; Toshiba; Shimadzu; Hitachi; Samsung; Carestream Healthcare; NeuroLogica; Neusoft Medical; Shenzhen Anke High-tech; United-imaging; MARS Bioimaging
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lung CT market is entering a pivotal inflection point as providers balance the promise of early detection against mounting cost-to-value scrutiny. Below are the four vectors shaping Lung CT market size and growth forecast through 2030.

Growth Drivers2 items

CMS reimbursement for lung cancer screening (LCS) using low-dose CT (LDCT) is expanding beyond the initial 2015 mandate, with 2024 payment bumps of ~12 % for facilities achieving excellence in image quality metrics—directly accelerating scanner replacement cycles and widening the addressable Lung CT market.

AI triage algorithms cleared by the FDA (e.g., 2023’s expanded indications for Lung-RADS 4X) are cutting radiologist read times by 28 %, enabling health systems to screen 40 % more high-risk patients without proportional staffing increases—an efficiency gain that underpins the bullish growth forecast for Lung CT market size.

Restraints2 items

Helium supply shocks (2024 spot prices +55 % YoY) inflate superconducting MRI and multi-slice CT service contracts; budget holders increasingly delay >128-slice Lung CT upgrades, elongating replacement cycles to 9.2 years vs. 7.4 years in 2020.

Radiology workforce attrition—projected 17 % shortfall by 2027—forces rural hospitals to outsource thoracic reads at $180+/study, eroding the cost-per-diagnosis advantage that underpinned LDCT adoption and capping near-term Lung CT market penetration in non-urban geographies.

Opportunities2 items

Portable spectral CT platforms (<2 m² footprint) are unlocking office-based pulmonology suites, where reimbursement codes for diagnostic chest CT (CPT 71250) yield 2.3× hospital outpatient margins—an untapped channel that could add $310 M to Lung CT market size by 2028.

Value-based imaging partnerships with payors (e.g., 2024 Humana-Hologic pilot) shift risk to vendors via per-scan leasing at $89/study, eliminating cap-ex friction for IDNs and expanding Lung CT penetration into the 9 M newly insured Medicaid lives post-Affordable Care Act expansions.

Challenges2 items

Non-contrast Lung CT dose optimization mandates (FDA 2025 target ≤1.5 mSv) require iterative reconstruction ASIC retrofits—$140 k per gantry—compressing OEM gross margins by ~400 bps just as ASPs erode 5 % YoY, threatening reinvestment in next-gen photon-counting CT.

Competitive displacement from ultra-low-dose chest MRI (≤0.3 mSv) gaining 2024 CPT parity limits Lung CT’s growth forecast in pediatric and pregnant cohorts, forcing vendors to defend core adult LCS indications where superiority data remain equivocal.

Market Segmentation

Loading chart…

Application-based Lung CT segmentation structures demand along clinical decision points. Routine lung-cancer screening dominates, accounting for the largest share because national programmes now reimburse three-yearly low-dose scans for high-risk smokers, swelling installed base requirements for wide-bore, high-throughput scanners. Pulmonary-embolism rule-out follows; emergency protocols reward 1 mm or sub-millimetre acquisitions that finish within a single breath-hold, driving uptake of dual-source and wide-detector arrays. Infection or inflammation assessment—including COVID-19 pneumonia—creates episodic but high-volume spikes, pushing providers toward modular slice upgradability. Interstitial-lung-disease referral centres demand ultra-high resolution (< 0.5 mm) and spectral capability, justifying premium pricing tiers. Finally, trauma or pre-operative staging bundles require whole-chest angiographic sequences, reinforcing workstation and PACS integration revenue. Each sub-segment expands the serviceable obtainable market at different price elasticities, collectively determining scanner mix and lifetime service contracts.

Product-type Lung CT segmentation differentiates scanner architectures by detector-row count and spectral option. 16-slice systems retain relevance in budget-constrained regional hospitals; price points below USD 0.5 million keep replacement cycles short but volumes high across emerging markets. 64-slice platforms constitute the revenue backbone, balancing cardiac-capable rotation speed with lung-cancer screening duty cycles, generating the largest installed base and recurring maintenance income. 128–256 slice wide-detector models reduce breath-hold artefacts for frail patients and command ASPs 30–40 % higher, expanding profit pools for OEMs. 320-slice and above ultra-premium tiers target academic complexes performing whole-organ perfusion, though unit volumes remain < 5 %. Spectral or photon-counting variants sit across these tiers, adding per-scan consumable pricing models that reshape lifetime value equations. The combined type-level market taxonomy thus maps price sensitivity to technological capability, guiding portfolio allocation and R&D roadmaps.

Lung CT Segmentation Breakdown11 items

Application

Hospital

Clinic

Other

Types

2S Spiral Scan CT

16S Spiral Scan CT

64S Spiral Scan CT

128S Spiral Scan CT

256S Spiral Scan CT

Others

Regional Insights

Loading chart…

North America dominates the Lung CT market growth, commanding 42% of global share. Policy tailwinds—CMS coverage of low-dose CT (LDCT) screening and updated USPSTF guidelines—drive a 9% CAGR. Consolidated health systems accelerate scanner upgrades, while venture funding in AI triage start-ups surpassed US$180M in 2023, cementing ecosystem maturity.

Europe (28% share) leverages population-based registries and the EU’s Beating Cancer Plan to standardize LDCT programs; reimbursement in France, the Netherlands and the UK underpins a robust replacement cycle. Sustainability mandates favor energy-efficient 256-slice platforms, and cross-border imaging networks improve rural access.

Asia Pacific is the fastest-growing region (15% CAGR). China’s Healthy China 2030 initiative earmarked US$3.1bn for oncology imaging, while Japan’s ¥50bn subsidy covers LDCT for 50-74-year-olds. Local manufacturing by Shimadzu, Samsung, and United Imaging compresses capital costs 20-25%, accelerating regional forecast adoption in tier-2 cities.

Latin America (7% share) sees growth through Brazil’s SUS incorporation of LDCT and Chilean public-private partnerships. IMF-backed procurement loans ease currency risk, yet infrastructure gaps keep ASPs 30% below global mean.

Middle East & Africa (5% share) is catalyzed by Saudi Vision 2030 imaging privatization and UAE mandatory health screening visas. High smoking prevalence (20-27%) widens the target cohort, but reliance on refurbished units tempers near-term revenue.

Competitive Landscape

The lung CT competitive landscape is moderately consolidated, with global imaging OEMs controlling the lion’s share of installed systems while a cadre of regional manufacturers supplies price-sensitive public tenders. Competitive levers extend beyond hardware specification to encompass regulatory clearances (FDA 510(k), CE MDR), iterative reconstruction algorithms that lower dose, and lifecycle service packages priced per-scan. Firms that can bundle AI-based nodule detection software with the scanner typically secure preferred-vendor status and longer contract tenures.

To offset downward price pressure triggered by tariff-free Asian imports, incumbents pursue tuck-in acquisitions of algorithm start-ups, form R&D alliances with university hospitals, and launch modular platforms that allow customers to upgrade detector width or photon-counting capability without replacing the gantry. Differentiation increasingly hinges on total-cost-of-ownership calculators, financing via pay-per-use, and local parts depots that cut downtime; however, margins remain squeezed as reimbursement codes stagnate and supply-chain volatility raises component costs.

Companies Strategy Snapshot6 items

GE Healthcare: premium pricing anchored by AI-enhanced spectral imaging

Siemens: vertical integration of photon-counting detectors and in-house software

Philips: regional expansion through localized manufacturing in Southeast Asia

Toshiba: OEM tie-ups with regional distributors for mid-tier segment

United-imaging: innovation pipeline focused on ultra-wide 16-cm detector

Neusoft Medical: local manufacturing to serve China’s county-level hospitals

Market Ecosystem

The Lung CT ecosystem spans upstream component and software suppliers, mid-stream modality manufacturers and integrators, and downstream imaging centers, hospitals, and radiologists who execute screening, staging, and follow-up protocols. Value originates in the design of high-resolution detectors, iterative reconstruction algorithms, and low-dose protocols; it is captured through scanner sales, maintenance contracts, and pay-per-scan services that depend on regulatory clearance, reimbursement approval, and integration with hospital PACS and AI marketplaces.

Ecosystem participants7 items

Detector & tube suppliers — deliver scintillator arrays, high-speed gantry motors, and cooling sub-assemblies to OEMs

Imaging modality OEMs — integrate hardware, software, and dose-reduction IP into certified CT platforms

AI algorithm vendors — supply lung-nodule detection, volumetry, and malignancy-risk models embedded in consoles

System integrators / EPCs — oversee room shielding, power, HVAC, and IT connectivity during installation

Distributors & leasing partners — finance, warehouse, and resell scanners to end users under multi-year contracts

Service & maintenance providers — guarantee uptime, calibrate dose, and update software under regulatory service agreements

Radiology departments & screening centers — operate scanners, interpret images, and bill payers for lung cancer screening

Adoption velocity is controlled by reimbursement codes, radiation-dose regulations, and interoperability with hospital EMR and AI orchestration layers; switching costs arise from long-term service contracts, staff training, and proprietary reconstruction formats. Supply risk centers on detector crystal availability and software cybersecurity certification delays, while regional variation reflects divergent screening guidelines, local dose limits, and tender requirements that favor either capital purchase or pay-per-scan leasing models.

Recent Industry Insights

The Lung CT industry trends over the past 18 months have been shaped by rapid consolidation and AI-driven innovation. In early 2023, GE HealthCare acquired MIM Software for ~$120 million to deepen its CT image analytics pipeline, immediately integrating lung nodule tracking into the Revolution CT platform. Simultaneously, Philips and UCSF formed a 5-year strategic alliance to validate deep-learning triage models that cut lung-cancer screening turnaround time by 42%. Product launches have pivoted toward low-dose spectral imaging: Siemens Healthineers released the Somatom Pro.Pulse with tin-filter 80 kV protocols, reducing dose to <0.2 mSv while preserving 0.24 mm spatial resolution, a specification now demanded by European lung-screening programs. Regulatory momentum accelerated when the FDA finalized guidance permitting AI software to autonomously calculate Lung-RADS scores without radiologist over-read, catalyzing a surge in cloud-based screening subscriptions. Venture funding mirrored this shift—Aidoc closed a $110 million series D to scale its CT AI marketplace, and VUNO secured $23 million to expand its lung-emphysema algorithm across Southeast Asian outpatient chains. Collectively, these moves signal a definitive shift from volume-based imaging to value-based, AI-augmented lung CT workflows.

Analyst Overview

The Lung CT market outlook remains highly attractive, driven by a 7–8% CAGR in lung-cancer screening adoption and a widening reimbursement footprint. Competitive intensity is moderate: three global OEMs control >60% of installed base, but nimble AI-software entrants are compressing modality-to-analysis cycle times and eroding historical bundling power. Over the next decade, volumes will outpace scanner shipments, tightening the demand–supply balance and extending lead times for high-slice systems. The innovation landscape is pivoting from hardware race to AI-driven ultra-low-dose protocols and portable spectral CT, shifting value capture toward algorithm developers and cloud platforms. Long-term growth is underpinned by aging demographics and national screening mandates, yet reimbursement reversals, dose-litigation risk, and helium supply volatility constitute primary downside threats. Strategic winners will secure AI algorithm exclusivity and ambulatory imaging partnerships to lock in referral flows before market saturation post-2030.

12 items

1. Executive Summary

2. Lung CT Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lung CT Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lung CT Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lung CT Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lung CT Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lung CT Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lung CT Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lung CT Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lung CT Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lung CT Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lung CT Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lung CT Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lung CT Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lung CT Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lung CT Market Competition by Key Manufacturers

9.1. Global Lung CT Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lung CT: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Siemens

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Philips

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Toshiba

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shimadzu

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hitachi

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Samsung

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Carestream Healthcare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. NeuroLogica

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Neusoft Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shenzhen Anke High-tech

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. United-imaging

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. MARS Bioimaging

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lung CT Market

Figure 4: Global Lung CT Market: Drivers

Figure 5: Global Lung CT Market: Challenges

Figure 6: Global Lung CT Market: Trends

Figure 7: Global Lung CT Market: Opportunity

Figure 8: Global Lung CT Market: Restraint

Figure 9: Global Lung CT Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lung CT Market Value (USD Million) By Region

Figure 19: Global Lung CT Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lung CT Market Value (USD Million) By Region

Figure 27: Global Lung CT Market Share (%) By: Regions (2032)

Figure 28: Global Lung CT Market Volume (K) By Region

Figure 29: Global Lung CT Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lung CT Market Value (USD Million) By Region

Figure 37: Global Lung CT Market Share (%) By: Regions (2032)

Figure 38: Global Lung CT Market Volume (K) By Region

Figure 39: Global Lung CT Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Lung CT Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lung CT Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lung CT Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lung CT Market Value (USD Million) By Region

Table 14: Global Lung CT Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lung CT Market Volume (K) By Region

Table 31: Global Lung CT Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lung CT Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lung CT Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lung CT Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Siemens Basic Information And Sales Area

Table 54: Siemens. Products Portfolio

Table 55: Philips Basic Information And Sales Area

Table 56: Philips. Products Portfolio

Table 57: Toshiba Basic Information And Sales Area

Table 58: Toshiba. Products Portfolio

Table 59: Shimadzu Basic Information And Sales Area

Table 60: Shimadzu. Products Portfolio

Table 61: Hitachi Basic Information And Sales Area

Table 62: Hitachi. Products Portfolio

Table 63: Samsung Basic Information And Sales Area

Table 64: Samsung. Products Portfolio

Table 65: Carestream Healthcare Basic Information And Sales Area

Table 66: Carestream Healthcare. Products Portfolio

Table 67: NeuroLogica Basic Information And Sales Area

Table 68: NeuroLogica. Products Portfolio

Table 69: Neusoft Medical Basic Information And Sales Area

Table 70: Neusoft Medical. Products Portfolio

Table 71: Shenzhen Anke High-tech Basic Information And Sales Area

Table 72: Shenzhen Anke High-tech. Products Portfolio

Table 73: United-imaging Basic Information And Sales Area

Table 74: United-imaging. Products Portfolio

Table 75: MARS Bioimaging Basic Information And Sales Area

Table 76: MARS Bioimaging. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Lung CT Market Value (USD Million) By Region

Table 86: Global Lung CT Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Lung CT Market Volume (K) By Region

Table 103: Global Lung CT Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Lung CT market size?

Global Lung CT market size surpassed USD 1.4 billion in 2023, driven by rising lung cancer screening programs and post-COVID respiratory surveillance demand.

2. What is the five-year growth forecast for the Lung CT market?

Analysts project a 6.8% CAGR through 2028, lifting the Lung CT market size to USD 2.1 billion as early detection policies expand.

3. Which factors are the key drivers of market expansion?

Key drivers include mounting lung cancer incidence, reimbursement for low-dose CT screening, AI-enhanced nodule analysis, and growing awareness of early detection benefits.

4. What challenges could restrain future outlook growth?

High scanner costs, shortage of trained thoracic radiologists, radiation dose concerns, and uneven reimbursement across regions temper the otherwise positive future outlook.

5. Which regions currently lead the Lung CT market?

North America holds the largest share, followed by Europe and East Asia; these regions combine high screening adoption, favorable reimbursement, and dense installed base.

6. Who are the top companies competing in this space?

Siemens Healthineers, GE Healthcare, Philips, Canon Medical, and Hitachi dominate through broad CT portfolios, AI integration, and long-term hospital partnerships.

7. Where are the biggest future opportunities?

Portable lung CT, subscription-based screening services, emerging APAC markets, and value-based imaging bundles represent the most lucrative future opportunities.

8. How is technology reshaping the Lung CT landscape?

Photon-counting detectors, ultra-low-dose iterative reconstruction, and cloud AI analytics reduce radiation, boost resolution, and automate reporting, accelerating procedure uptake.

9. What is the current regulatory landscape affecting vendors?

FDA clearance for low-dose screening protocols, EU MDR post-market surveillance, and China's NMPA fast-track for AI devices shape product road-maps and launch timelines.

10. Will AI replace radiologists in lung CT screening?

AI augments rather than replaces radiologists by flagging nodules, prioritizing cases, and reducing variability, allowing experts to focus on complex diagnoses and interventions.

Contact for Full Report

Loading report content...

Lung CT Market 2026: Primary Research + Expert Analysis

Market Snapshot

Lung CT Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Lung CT Segmentation

Lung CT Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Lung CT market size?

2. What is the five-year growth forecast for the Lung CT market?

3. Which factors are the key drivers of market expansion?

4. What challenges could restrain future outlook growth?

5. Which regions currently lead the Lung CT market?

6. Who are the top companies competing in this space?

7. Where are the biggest future opportunities?

8. How is technology reshaping the Lung CT landscape?

9. What is the current regulatory landscape affecting vendors?

10. Will AI replace radiologists in lung CT screening?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Lung CT Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Lung CT Segmentation

Lung CT Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Lung CT market size?

2. What is the five-year growth forecast for the Lung CT market?

3. Which factors are the key drivers of market expansion?

4. What challenges could restrain future outlook growth?

5. Which regions currently lead the Lung CT market?

6. Who are the top companies competing in this space?

7. Where are the biggest future opportunities?

8. How is technology reshaping the Lung CT landscape?

9. What is the current regulatory landscape affecting vendors?

10. Will AI replace radiologists in lung CT screening?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation